Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Drug Dosing in Obesity

Volume I: Antimicrobials
Buch | Hardcover
XIII, 133 Seiten
2016 | 1st ed. 2016
Springer International Publishing (Verlag)
978-3-319-44032-3 (ISBN)

Lese- und Medienproben

Drug Dosing in Obesity -
CHF 194,70 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

This book provides an up to date review on antimicrobials dosing in obese patients, including practice recommendations for clinical use. The book is written by a group of doctors and pharmacists working in infectious diseases practice and research.

The introductory chapter outlines the important physiological changes in obesity including factors affecting the dosing of antimicrobials in obese patients. The introductory chapter is followed by ten chapters covering the major classes of antibiotics, antifungals, and antivirals. Each chapter briefly discusses the pharmacokinetics changes related to obesity and a summary of the relevant up-to-date literature. Specific dosing recommendations are provided for each class supplemented by real-life examples as clinical cases that are included as an appendix to the book. The book is a useful resource for clinicians, students and researchers needing up-to-date information on antimicrobial dosing in obese patients. Doctors, pharmacists, nurses working in hospital settings, and students of health courses (medical, pharmacy and nursing students) will find this book particularly useful.

Dr Syed Tabish R. Zaidi is an experienced clinical pharmacist with special interest in Infectious Diseases and Translational Research. Dr. Zaidi is the course coordinator of postgraduate clinical pharmacy coursework at the University of Tasmania. He has a special interest in obesity research and currently supervising graduate students on examining medication use in obese patients within Australian hospitals. He is also leading several practice-based research projects in Australia, France and Middle East.

Betalactams: Penicillins.- Betalactams: Cephalosporins.- Aminoglycosides.- Quinolones.- Carbapenems.- Glycopeptides and antibiotics for Gram-Positive Bacterial Infections.- Azole antifungals.- Echinocandins antifungals.- Polyene antifungals.- Miscellaneous antimicrobials.    

 "With rising populations of obese patients and issues regarding antimicrobial resistance, this book is well timed. ... Chapters end with a thorough reference list. Summary tables act as a quick reference point for readers. ... This comprehensive book is well structured, easy to use and has a wealth of useful information. It will be of particular value to those involved in managing obese patients with infections." (Preet Panesar, British Journal of Hospital Medicine, Vol. 78 (4), April, 2017)

Erscheinungsdatum
Zusatzinfo XIII, 133 p. 2 illus.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pharmazie PTA / PKA
Studium 1. Studienabschnitt (Vorklinik) Physiologie
Schlagworte Antibiotics • Antifungals • Human Physiology • Infectious Diseases • Medicine • Pharmacokinetics • pharmacotherapy • Pharmacy • Physiological changes in obesity
ISBN-10 3-319-44032-2 / 3319440322
ISBN-13 978-3-319-44032-3 / 9783319440323
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hans-Christian Pape; Armin Kurtz; Stefan Silbernagl

Buch (2023)
Thieme (Verlag)
CHF 139,95

von Stefan Gründer; Klaus-Dieter Schlüter

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 96,55